Different β-blockers and initiation time in patients undergoing noncardiac surgery: A meta-analysis

American Journal of the Medical Sciences

Volumn 347, Issue 3, 2014, Pages 235-244

  Dai, Neng ^a   Xu, Da Chun ^a   Zhang, Ji ^a   Wei, Yi Dong ^a   Li, Wei Ming ^a   Fan, Bing ^b   Xu, Ya Wei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

b blocker; Cardiovascular complications; Noncardiac surgery

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL; PLACEBO; PROPRANOLOL;

BRADYCARDIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CORONARY RISK; HEART INFARCTION; HUMAN; HYPOTENSION; META ANALYSIS; NONCARDIAC SURGERY; PERIOPERATIVE PERIOD; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; BRADYCARDIA; HUMANS; HYPOTENSION; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84896733887     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31828c607c     Document Type: Review

References (36)

1. Mangano DT. Peri-operative cardiovascular morbidity: New developments. Best Pract Res Clin Anaesthesiol 1999;13:335-48.
2. Fleisher LA, Eagle KA. Clinical practice: Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001;345:1677-82.
3. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20.
4. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998;88:7-17.
5. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: A randomized controlled trial (DECREASE-IV). Ann Surg 2009;249:921-6.
6. Urban MK, Markowitz SM, Gordon MA, et al. Postoperative prophylactic administration of beta-Adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000;90:1257-61.
7. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:e159-241.
8. POISE Study Group, Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008; 371:1839-47.
9. Talati R, Reinhart KM, White CM, et al. Outcomes of perioperative b-blockade in patients undergoing noncardiac surgery: A meta-Analysis. Ann Pharmacother 2009;43:1181-8.
10. Wallace AW, Au S, Cason BA. Perioperative b-blockade: Atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 2011;114:824-36.
11. Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-Analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 2011;39:91-2.
12. Coats AJ, Shewan LG. Statement on authorship and publishing ethics in the International Journal of Cardiology. Int J Cardiol 2011; 153:239-40.
13. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
14. Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-Analysis of randomized controlled trials. J Clin Epidemiol 1997;50:683-91.
15. London MJ, Zaugg M, Schaub MC, et al. Perioperative beta-Adrenergic receptor blockade: Physiologic foundations and clinical controversies. Anesthesiology 2004;100:170-5.
16. Yang H, Raymer K, Butler R, et al. The effects of perioperative betablockade: Results of the Metoprolol after Vascular Surgery (MaVS) Study, a randomized controlled trial. Am Heart J 2006;152:983-90.
17. Brady AR, Gibbs JS, Greenhalgh RM, et al. Perioperative betablockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg 2005;41:602-9.
18. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: Randomised placebo controlled, blinded multicentre trial. BMJ 2006;332:1482.
19. Landesberg G, Luria MH, Cotev S, et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 1993;341:715-9.
20. Bayliff CD, Massel DR, Inculet RI, et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 1999;67:182-6.
21. Eagle K-A, Berger P-B, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-53.
22. ZauggM, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: A doubleblinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007;107:33-44.
23. Ryder DL. The use of beta-blockers to decrease adverse perioperative cardiac events. Dimens Crit Care Nurs 2008;27:47-53.
24. Kertai MD, Bax JJ, Klein J, et al. Is there any reason to withhold beta blockers from high-risk patients with coronary artery disease during surgery? Anesthesiology 2004;100:4-7.
25. Jakobsen CJ, Bille S, Ahlburg P, et al. Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy. Acta Anaesthesiol Scand 1997;41:1324-30.
26. Dunzendorfer S, Wiedermann CJ. Modulation of neutrophil migration and superoxide anion release by metoprolol. J Mol Cell Cardiol 2000;32:915-24.
27. Senzaki H, Paolocci N, Gluzband YA, et al. Beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circ Res 2000;86:807-15.
28. Prabhu SD, Chandrasekar B, Murray DR, et al. Beta-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000;101:2103-9.
29. Jenkins NP, Keevil BG, Hutchinson IV, et al. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 2002;112:269-74.
30. Frishman WH, Saunders E. b-Adrenergic blockers. J Clin Hypertens (Greenwich) 2011;13:649-53.
31. Nilsson OR, Atterhög JH, Castenfors J, et al. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives. Acta Med Scand 1984;216:301-7.
32. Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients: Population based, retrospective cohort study. BMJ 2005;331:932.
33. Badgett RG, Lawrence VA, Cohn SL. Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade. Anesthesiology 2010;113:585-92.
34. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769-812.
35. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine; Society for Vascular Surgery. J Am Coll Cardiol 2009;54:e13-118.
36. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999;88:477-82.